Education
About Us
Working with TipRanks
Follow Us
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 17.16B | ₹ 12.96B | ₹ 10.03B | ₹ 8.06B | ₹ 8.09B |
| Gross Profit | ₹ 7.53B | ₹ 6.22B | ₹ 5.78B | ₹ 4.48B | ₹ 4.78B |
| Operating Income | ₹ 2.14B | ₹ 1.71B | ₹ 1.49B | ₹ 696.50M | ₹ 1.16B |
| EBITDA | ₹ 1.98B | ₹ 2.36B | ₹ 1.51B | ₹ 1.01B | ₹ 1.48B |
| Net Income | ₹ 1.16B | ₹ 1.62B | ₹ 992.90M | ₹ 616.00M | ₹ 933.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 5.53B | ₹ 5.06B | ₹ 5.00B | ₹ 4.48B | ₹ 3.52B |
| Total Assets | ₹ 15.18B | ₹ 10.78B | ₹ 9.85B | ₹ 8.57B | ₹ 7.75B |
| Total Debt | ₹ 357.30M | ₹ 45.90M | ₹ 72.14M | ₹ 86.30M | ₹ 121.40M |
| Net Debt | ₹ -5.00B | ₹ -5.01B | ₹ -4.93B | ₹ -4.40B | ₹ -3.40B |
| Total Liabilities | ₹ 7.48B | ₹ 3.66B | ₹ 3.96B | ₹ 3.45B | ₹ 3.19B |
| Stockholders' Equity | ₹ 7.70B | ₹ 7.12B | ₹ 5.89B | ₹ 5.11B | ₹ 4.56B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 636.10M | ₹ 171.10M | ₹ 497.70M | ₹ 911.80M | ₹ 970.70M |
| Operating Cash Flow | ₹ 653.60M | ₹ 278.70M | ₹ 582.90M | ₹ 1.01B | ₹ 1.05B |
| Investing Cash Flow | ₹ 308.00M | ₹ 217.40M | ₹ 181.10M | ₹ 47.40M | ₹ 1.73B |
| Financing Cash Flow | ₹ -655.90M | ₹ -443.80M | ₹ -244.80M | ₹ -94.60M | ₹ -89.70M |